{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:45:06Z","timestamp":1762101906988,"version":"3.40.5"},"reference-count":27,"publisher":"Codon Publications","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.aller.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,9,3]],"date-time":"2016-09-03T00:23:21Z","timestamp":1472862201000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Primary immunodeficiencies in Chile evaluated through ICD-10 coded hospital admissions"],"prefix":"10.15586","volume":"45","author":[{"given":"C.","family":"Poli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hoyos-Bachiloglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7904-262X","authenticated-orcid":false,"given":"A.","family":"Borzutzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2016.05.004_bib0140","first-page":"54","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency","volume":"2","author":"Al-Herz","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.aller.2016.05.004_bib0145","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2009.10.013","article-title":"Primary immunodeficiencies: 2009 update","volume":"124","author":"International Union of Immunological Societies Expert Committee on Primary I","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.05.004_bib0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2249.2011.04542.x","article-title":"The European internet-based patient and research database for primary immunodeficiencies: update 2011","volume":"167","author":"Gathmann","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.aller.2016.05.004_bib0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2011.06289.x","article-title":"Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives","volume":"1250","author":"Errante","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.aller.2016.05.004_bib0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2011.06379.x","article-title":"Primary immunodeficiency diseases in the Middle East","volume":"1250","author":"Al-Muhsen","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.aller.2016.05.004_bib0165","article-title":"Epidemiology of primary immunodeficiency in Iceland","author":"Ludviksson","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2016.05.004_bib0170","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s10875-014-0102-8","article-title":"Prevalence and morbidity of primary immunodeficiency diseases, United States 2001\u20132007","volume":"34","author":"Kobrynski","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2016.05.004_bib0175","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10875-007-9103-1","article-title":"Population prevalence of diagnosed primary immunodeficiency diseases in the United States","volume":"27","author":"Boyle","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2016.05.004_bib0180","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s10875-013-9901-6","article-title":"A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside","volume":"33","author":"Bousfiha","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2016.05.004_bib0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10875-006-9052-0","article-title":"Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry","volume":"27","author":"Leiva","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2016.05.004_bib0190","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaci.2004.01.761","article-title":"Identifying undiagnosed primary immunodeficiency diseases in minority subjects by using computer sorting of diagnosis codes","volume":"113","author":"Cunningham-Rundles","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.aller.2016.05.004_bib0195","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1007\/s10875-012-9838-1","article-title":"Using intravenous immunoglobulin (IVIG) to treat patients with primary immune deficiency disease","volume":"33","author":"Bonagura","year":"2013","journal-title":"J Clin Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.aller.2016.05.004_bib0200","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1007\/s10875-012-9845-2","article-title":"Overview of routes of IgG administration","volume":"33","author":"Torgerson","year":"2013","journal-title":"J Clin Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.aller.2016.05.004_bib0205","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.tmrv.2009.09.011","article-title":"The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline","volume":"24","author":"Shehata","year":"2010","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.aller.2016.05.004_bib0210","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.mcna.2012.04.010","article-title":"Immunotherapy for primary immunodeficiency diseases","volume":"96","author":"Wood","year":"2012","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.aller.2016.05.004_bib0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.aller.2016.05.004_bib0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10875-012-9773-1","article-title":"Examining the use of ICD-9 diagnosis codes for primary immune deficiency diseases in New York State","volume":"33","author":"Resnick","year":"2013","journal-title":"J Clin Immunol"},{"year":"2014","series-title":"Base de datos de egresos hospitalarios","author":"Departamento de Estad\u00edsticas e Informaci\u00f3n de Salud MINSAL","key":"10.1016\/j.aller.2016.05.004_bib0225"},{"year":"2011","series-title":"OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.3.1","author":"Dean","key":"10.1016\/j.aller.2016.05.004_bib0230"},{"key":"10.1016\/j.aller.2016.05.004_bib0235","first-page":"162","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency","volume":"5","author":"Al-Herz","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.aller.2016.05.004_bib0240","article-title":"Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID)","author":"Condino-Neto","year":"2014","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.aller.2016.05.004_bib0245","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1309\/AJCP4ZDKJ4ICOUAT","article-title":"Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis","volume":"139","author":"Rosado","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.aller.2016.05.004_bib0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.aller.2012.01.003","article-title":"Advancing the management of primary immunodeficiency diseases in Latin America: Latin American Society for Immunodeficiencies (LASID) Initiatives","volume":"40","author":"Condino-Neto","year":"2012","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.aller.2016.05.004_bib0255","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10875-013-9975-1","article-title":"Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulin","volume":"34","author":"Stonebraker","year":"2014","journal-title":"J Clin Immunol"},{"year":"2012","series-title":"The plasma proteins market in Chile 2010. Orange, Connecticut","author":"Bureau","key":"10.1016\/j.aller.2016.05.004_bib0260"},{"key":"10.1016\/j.aller.2016.05.004_bib0265","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2004.10.012","article-title":"Development of population-based newborn screening for severe combined immunodeficiency","volume":"115","author":"Chan","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.05.004_bib0270","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00296-011-2050-4","article-title":"Rising hospitalization rates of Kawasaki Disease in Chile between 2001 and 2007","volume":"32","author":"Borzutzky","year":"2012","journal-title":"Rheumatol Int"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054616300957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054616300957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:50:48Z","timestamp":1609455048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054616300957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0301054616300957"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2016.05.004","relation":{},"ISSN":["0301-0546"],"issn-type":[{"type":"print","value":"0301-0546"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary immunodeficiencies in Chile evaluated through ICD-10 coded hospital admissions","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SEICAP. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}